Prophylaxis of graft infection with rifampicin-bonded gelseal graft: 2-year follow-up of a prospective clinical trial

Vascular

Volumn 4, Issue 2, 1996, Pages 200-204

  D'addato, M ^a   Curti, T ^a   Freyrie, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Dacron prostheses; infection; rifampicin; vascular graft

Indexed keywords

CEFALOTIN; CEFAMANDOLE; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; DACRON; GENTAMICIN; RIFAMPICIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

EID: 0029880789     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099600400216     Document Type: Article

References (12)

1. Cormier JM, Ward AS, Langneau S, Janneau D. Infections complicating aorto-iliac surgery. J Cardiovasc Surg (Torino) 1980; 21: 303–314.
2. Bunt TJ. Synthetic vascular graft infection. I. Graft infection. Surgery 1983; 93: 733–746.
3. Richardson RL, Pate JW, Wolf RY. The outcome of antibiotic-soaked arterial grafts in guinea pigs wound contaminated with E. coli or S. aureus. J Thorac Cardiovasc Surg 1970; 59: 635–637.
4. Powell TW, Burnham JJ, Johnson GA. A passive system using rifampicin to create an infection-resistant vascular prosthesis. Surgery 1983; 94: 765–769.
5. Chervu A, Moore WS, Chvapil M, Henderson F. Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system. J Vasc Surg 1991; 13: 897–900.
6. Goëu-Brissonière O, Leport C, Bascourt F. Prevention of vascular graft infection by rifampicin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg 1991; 5: 408–412.
7. Avramociv J, Fetcher JP. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein sealed Dacron graft in combination with parenteral cephalosporin. J Cardiovasc Surg (Torino) 1992; 33: 70–74.
8. Freyrie A, Curti T, Rodio M, et al. Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection, Int Angio 1992; 11: 113–116.
9. D'Addato M, Curti T, Freyrie A, Agus GB, Bertini D, Biasi GM. Prevention of early graft infection with rifampicin-bonded gelseal graft. A multicentre experimental study. Cardiovasc Surg 1994; 2–2: 254–258.
10. Torsello G, Sandmann W, Gehert A, Jungblut RM. In situ replacement of infected vascular prostheses with rifampicin-soaked vascular grafts: early results. J Vasc Surg 1993; 17: 768–773.
11. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg 1972; 176: 321–333.
12. May ARL, Darling RC, Brewster DC, Darling CS. A comparison of the use of cephalothin and oxacillin in vascular surgery. Arch Surg 1980; 115: 56–62.